“…Given the number of studies, the range of study types conducted, and the number of independent observations in different countries that have been made now over several decades, it is unlikely that any form of systematic error in either the selection or follow-up of the study subjects could explain these findings. Apart from the obvious limitations of reviews of routine data and proportionate mortality studies related to the comparability of numerator and denominator data, as in most epidemiologic studies, it is possible to identify the limitations of these investigations including issues related to study size and power particularly for the hematologic cancers, the reanalysis of existing datasets rather than the testing of hypotheses for which the studies were designed (15,24), possible selection bias in the definition of the case group (35) or through loss to follow-up (19,23), and possible information bias through obtaining exposure information from next of kin (25,27), from union membership records (11-14, 16, 17, 22), census data at fixed points in time (19,21), or from the last known occupation recorded on cancer registrations or death certificates (26,34). There is, however, no obvious differential misclassification between exposed and unexposed groups that would introduce a bias in the same direction across all studies.…”